Randomized, double-blind, Phase II Study of FOLFOX/Bevacizumab with MetMAb versus Placebo as First-Line Treatment for Patients with Metastatic Colorectal Cancer
Conditions
Colorectal Cancer
What is the purpose of this trial?
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Genentech
- Dates:
- October 2011
- Last Updated:
- Study HIC#:
- 1108008917
Clinicaltrials.gov ID: Yale3509594
